1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Macrolides: new trials by email Literature Review of Macrolides trials Research Report on Macrolides
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia Ceftriaxone + Macrolide, Moxifloxacin or Levofloxacin, Piperacillin-tazobactam + Macrolide - Respiratory Tract Diseases, Influenza (Pandemic) | Phase 3 | Recruiting | UMC Utrecht | 20000 | 2016-04-11 | 2026-11-04 |
COVID-19 (1) · Community-Acquired Pneumonia (1) · Influenza, Human (1) · Lung Diseases (1) · Pneumonia (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
UMC Utrecht (1)
Australia (1) · Belgium (1) · Canada (1) · Colombia (1) · Croatia (1) · Czechia (1) · Estonia (1) · Finland (1) · France (1) · Germany (1) · Hungary (1) · India (1) · Ireland (1) · Israel (1) · Italy (1)
Colin McArthur, Dr (1) · Derek Angus, Prof (1) · John Marshall, Prof (1) · Lennie Derde, MD (1) · Luis Felipe Reyes, MD, MSc, PhD (1) · Marc Bonten, Prof (1) · Steve Webb, Prof (1)
PMID 32267771, PMID 32876697, PMID 33394942, PMID 33509275, PMID 33631065, PMID 34251506, PMID 34351721, PMID 34351722, PMID 34473343, PMID 34606578, PMID 35315874, PMID 36525245, PMID 36942550, PMID 36967714, PMID 37039790, PMID 37256341, PMID 37489818, PMID 37877585, PMID 37888913, PMID 40261382, PMID 40360262, PMID 42823695
2015 (1), 2023 (1)